CiMUS Principal Investigator Mª José Alonso enters the ‘US National Academy of Medicine’
Her Lab has pioneered numerous discoveries in the field of Pharmaceutical Technology and Nanomedicine. She becomes now the second scientist in Spain obtaining this distinction.
Professor María José Alonso, Principal Investigator at CiMUS and Full Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has been elected Member of the United States of America National Academy of Medicine (NAM). Considered one of the highest honors in the fields of health and medicine, this election recognizes individuals who have demonstrated outstanding professional achievement and commitment to service, distinguishing Professor Alonso’s career within a nomination that was promoted by Professor Patrick Couvreur, from the University of Paris Sud (France) and Professor Robert Langer, from Massachusets Institute of Technology (MIT, Cambridge, USA).
María José Alonso’s lab has pioneered numerous discoveries in the field of Pharmaceutical Technology and Nanomedicine. She has coordinated several research consortia financed by the World Health Organization (WHO), the Bill and Melinda Gates Foundation and the European Commission. Currently, she is involved in 5 EU Projects and coordinates the TRANS-INT EU Consortium.
She is the author of over 235 scientific contributions with more than 11,600 cites (H factor 65) and the inventor of 19 patent families. Due to the quality of her papers, she has been ranked among the Top Ten in Pharmacology (‘Times Higher Education International Ranking’). She also serves on the editorial board of 12 scientific journals.
Between 2006 and 2010 she was the Vice-rector of Research and Innovation of the USC. She has advised the Spanish Ministry of Sciences and Innovation in the elaboration of the Law of Sciences, Technology and Innovation (2011), and she has been part of the Advisory Council of the Ministry of Health in Spain.
Professor Alonso has also held responsibilities in several scientific societies, among them the Controlled Release Society (CRS), a global organization whose main goal is to broaden the knowledge and the applications of delivery science and technology. Before this last election, she was also a member of three other Academies: the Academy of Pharmacy of Galicia, the Royal Academy of Sciences in Galicia and the Royal Academy of Pharmacy of Spain.
About NAM (National Academy of Medicine)
Originally established as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors. NAM works alongside the National Academy of Sciences and National Academy of Engineering to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. The Academies also encourage education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science, engineering, and medicine. With their election, members make a commitment to volunteer their service in the Academies’ activities.